FDA approves first cancer drug based on Broad Institute science
November 20, 2025
November 20, 2025
CAMBRIDGE, Massachusetts, Nov. 20 [Category: Medical] -- The Broad Institute posted the following news:
* * *
FDA approves first cancer drug based on Broad Institute science
Highlights
* The new medicine, sevabertinib, is a pill approved for a type of lung cancer that previously had few treatment options.
* Genetic discoveries from Broad scientists laid the foundation for the development of the drug.
* This FDA appr . . .
* * *
FDA approves first cancer drug based on Broad Institute science
Highlights
* The new medicine, sevabertinib, is a pill approved for a type of lung cancer that previously had few treatment options.
* Genetic discoveries from Broad scientists laid the foundation for the development of the drug.
* This FDA appr . . .